However, DOK7 gene therapy significantly prolonged life span of ALS mice (166.3 ± 3.2 days) compared with non‐treated ALS mice (154.4 ± 2.7 days; Fig 3A). Here, DOK7 is linked to amyotrophic lateral sclerosis.